Cargando…
New drugs: big changes in conservative heart failure therapy?
During the last 20 years, the prognosis for heart failure (HF) with reduced ejection fraction has steadily improved due to advances in drug treatment and the consistent implementation of guideline-recommended evidence-based drug therapy. Nevertheless, the morbidity and mortality rates of patients wi...
Autores principales: | Berliner, Dominik, Bauersachs, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526100/ https://www.ncbi.nlm.nih.gov/pubmed/31106335 http://dx.doi.org/10.1093/ejcts/ezy421 |
Ejemplares similares
-
Current Drug Therapy in Chronic Heart Failure: the New Guidelines of the European Society of Cardiology (ESC)
por: Berliner, Dominik, et al.
Publicado: (2017) -
Drug treatment of heart failure in the elderly
por: Berliner, D., et al.
Publicado: (2018) -
Cardiooncology—dealing with modern drug treatment, long-term complications, and cancer survivorship
por: de Wall, Claudia, et al.
Publicado: (2021) -
Heart failure drug treatment: the fantastic four
por: Bauersachs, Johann
Publicado: (2021) -
Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
por: Wang, Dong, et al.
Publicado: (2023)